reSee.it - Tweets Saved By @birb

Posted - September 24, 2023 at 5:58 PM

Saved - September 25, 2023 at 12:35 PM

reSee.it AI Summary

During the VRBPAC meeting, a critical slide (16) was quickly shown, catching attention. In June 2021, Steve provided a safety update, mentioning the absence of vaccine-enhanced disease. Some adverse events were flagged but didn't prompt action. Notably, the Oct 2020 slide (16) is included in the presentation document. [Character count: 394]

@birb_k - KBirb

Quickest slide ever. VRBPAC meeting 10/22/2020, prep to launch injections. Steve Anderson, FDA/CBER Dir. of Biostatistics & Epidemiology. Screen cap of critical slide 16. Video clip starts at slide 15. Watch as he asks for slide 17, slide 16 flashes by. https://youtube.com/watch?v=1XTiL9rUpkg&t=9210s… 1/

@birb_k - KBirb

8 months later June 2021. Steve gives safety data update. This slide is shown. “Vaccine enhanced disease” missing. Then he says some Adverse Events of Special Interest (AESI’s) “obviously have now signaled,” but it did not appear to trigger any action. https://www.youtube.com/watch?v=70Xhn3K9SlQ&t=5817s 2/ https://t.co/dmSTQE9STi

@birb_k - KBirb

Note: The Oct 2020 flash-by slide 16 is included in the presentation ndocument uploaded to the VRBPAC event record. Link: https://www.fda.gov/media/143557/download 3/

@birb_k — KBirb

Posted - September 16, 2023 at 4:00 PM

Saved - September 17, 2023 at 7:02 AM

reSee.it AI Summary

Nipah outbreak in Kerala, India sparks concern. The lethal virus historically had low transmission. A 3-year study funded by NIHNIAID on Nipah raises questions about gain-of-function research. Moderna conducts Phase 1 trials for an mRNA vaccine, with NIHNIAID funding. Connections between Fauci, EcoHealth, and Moderna draw attention. Potential risks if a transmissible version of Nipah emerges.

@birb_k - KBirb

Nipah. Outbreak | Study | Vaccine. The unique combination of these 3 elements feels familiar, uncomfortable. A) OUTBREAK. Multiple outlets now reporting Nipah outbreak & isolation efforts in Kerala, India. Nipah has historically been low transmission and highly lethal. But… 1/

@birb_k - KBirb

Nipah. Outbreak | Study | Vaccine. B) STUDY. The NIH/NIAID funded a 3-year Cooperative Agreement program 2020-2022 on Nipah, while Fauci was in office. The awardee? Peter Daszak and EcoHealth Alliance. Was gain-of-function involved? (asking due to precedence) 2/ https://t.co/EBma02ygxi

@birb_k - KBirb

Nipah. Outbreak | Study | Vaccine. C) VACCINE. No Nipah vaccine has existed, but an mRNA candidate (of course) is in active Phase 1 trials. Who is doing the trial and has worldwide rights to the outcome? Moderna. Who funded the trial? NIH/NIAID (royalty?) History rhymes. 3/ https://t.co/LC7lFk24rB

@birb_k - KBirb

Will Nipah remain a deadly but low-transmission disease with localized, non-global consequences? Hopefully. But if a version manipulated for transmissibility leaked, that would be bad. In COVID context Fauci/NIAID had ties to EcoHealth & Moderna. Same apparently with Nipah. 4/ https://t.co/UOVmaYGJmw

reSee.it - Tweets Saved By @birb_k